Citation: M. Doren et G. Samsioe, Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995, HUM REP UPD, 6(5), 2000, pp. 419-426
Authors:
Li, C
Samsioe, G
Lidfelt, J
Nerbrand, C
Agardh, CD
Citation: C. Li et al., Important factors for use of hormone replacement therapy: A population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study, MENOPAUSE, 7(4), 2000, pp. 273-281
Citation: Jhh. Thijssen et al., Maturitas, the European Menopause Journal, becomes 'Official Journal of the European Menopause and Andropause Society', MATURITAS, 35(1), 2000, pp. 1-2
Authors:
Svartvik, L
Lidfeldt, J
Nerbrand, C
Samsioe, G
Schersten, B
Nilsson, PM
Citation: L. Svartvik et al., Dyslipidaemia and impaired well-being in middle-aged women reporting low Sense of Coherence - The Women's Health in the Lund Area (WHLA) Study, SC J PRIM H, 18(3), 2000, pp. 177-182
Authors:
Stevenson, J
Samsioe, G
Pines, A
Huber, J
Netelenbos, C
de Roo, G
Sitruk-Ware, R
Barentsen, R
Palacios, S
Koninckx, PR
Citation: J. Stevenson et al., Critical comments on the paper - "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women" by S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, E. Vittinghoff for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Published in: JAMA 1998; 280; 605-613., MATURITAS, 31(1), 1998, pp. 77-87